Brii Biosciences and VBI Vaccines Present Positive Data from Completed Phase 1b/2a Study on BRII-179 (VBI-2601) in Patients with Chronic Hepatitis B at the International Liver Congress 2021
Data demonstrate that BRII-179 (VBI-2601) induced both B cell (antibody) and T cell responses in…